Triglycerides/Glucose Index Is Associated with Sperm Parameters and Sperm DNA Fragmentation in Primary Infertile Men: A Cross-Sectional Study.

infertility insulin resistance risk factors semen parameters triglycerides/glucose index

Journal

Metabolites
ISSN: 2218-1989
Titre abrégé: Metabolites
Pays: Switzerland
ID NLM: 101578790

Informations de publication

Date de publication:
03 Feb 2022
Historique:
received: 13 01 2022
revised: 24 01 2022
accepted: 27 01 2022
entrez: 25 2 2022
pubmed: 26 2 2022
medline: 26 2 2022
Statut: epublish

Résumé

we aimed to investigate the relationship between the tyg index and both semen and hormonal characteristics in a cohort of primary infertile men. Summary answer: almost one in two primary infertile men presented with a triglycerides/glucose index (tyg) suggestive of insulin resistance (ir). overall, patients with tyg suggestive of ir showed worse clinical, hormonal, and semen parameters. What is already known: male factor infertility (MFI) is often associated with metabolic disorders such as diabetes mellitus and metabolic syndrome, where insulin resistance (IR) plays a relevant pathological role. Recently, TyG has been suggested as a user-friendly IR marker. serum hormones and the sperm DNA fragmentation index (SDF) were measured in every patient. The semen analysis was based on 2010 WHO reference criteria. Glucose and insulin levels were measured for every man after a 12-h overnight fast, and the homeostatic model assessment index (HOMA-IR) was then calculated and categorized using a 2.6 threshold. Similarly, fasting glucose and triglycerides levels were measured and the TyG index was calculated and categorized using an 8.1 threshold. Descriptive statistics and logistic regression models tested the association between the TyG and semen and hormonal characteristics. complete demographic, clinical, and laboratory data from 726 consecutive white European primary infertile men were considered for this analysis. Main results and the role of chance: the median (IQR) age was 39 (35-43) years. A TyG and HOMA suggestive for IR was found in 339 (46.6%) and 154 (21.2%) men, respectively. During the Spearman's test, the TyG index was highly correlated with HOMA-IR (rho = 0.46,

Identifiants

pubmed: 35208217
pii: metabo12020143
doi: 10.3390/metabo12020143
pmc: PMC8875300
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J R Coll Physicians Lond. 1997 Sep-Oct;31(5):546-51
pubmed: 9429194
Andrologia. 2018 Dec;50(11):e13140
pubmed: 30569651
Eur Urol. 2011 Oct;60(4):796-808
pubmed: 21733620
Front Endocrinol (Lausanne). 2018 May 25;9:268
pubmed: 29887834
Hum Reprod Update. 2018 Jan 1;24(1):86-105
pubmed: 29136166
Fertil Steril. 2020 Jun;113(6):1174-1182
pubmed: 32299615
Asian J Androl. 2021 Sep-Oct;23(5):501-509
pubmed: 33723100
Lipids Health Dis. 2017 Dec 12;16(1):241
pubmed: 29233142
Endocrinol Nutr. 2014 Dec;61(10):533-40
pubmed: 25174769
Diabetes Metab Syndr. 2019 Jan - Feb;13(1):272-277
pubmed: 30641711
Anat Rec. 1985 Sep;213(1):53-62
pubmed: 4073561
Diabetes Care. 2003 Dec;26(12):3320-5
pubmed: 14633821
Int J Obes (Lond). 2017 May;41(5):789-792
pubmed: 28104918
BJU Int. 2019 Jun;123(6):1070-1077
pubmed: 30328251
Hum Reprod Update. 2010 May-Jun;16(3):231-45
pubmed: 19934213
Int J Mol Sci. 2021 Feb 17;22(4):
pubmed: 33671459
Metab Syndr Relat Disord. 2008 Dec;6(4):299-304
pubmed: 19067533
Andrology. 2021 Nov;9(6):1843-1852
pubmed: 34169669
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):1307-1314
pubmed: 32755827
Eur Urol. 2009 Dec;56(6):1025-31
pubmed: 19297076
Andrology. 2020 Nov;8(6):1762-1769
pubmed: 32644296
Nat Rev Dis Primers. 2019 May 30;5(1):38
pubmed: 31147553
Andrology. 2013 Mar;1(2):229-39
pubmed: 23315971
Andrology. 2022 Jan;10(1):128-136
pubmed: 34369670
Andrology. 2021 Nov;9(6):1828-1842
pubmed: 34114375
Eur Urol. 2016 Dec;70(6):920-923
pubmed: 27343001
Minerva Endocrinol. 2009 Mar;34(1):1-9
pubmed: 19209124
Endocrinol Metab (Seoul). 2019 Jun;34(2):179-186
pubmed: 31257745
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Clin Exp Dermatol. 2008 May;33(3):239-42
pubmed: 18093239
Minerva Urol Nefrol. 2007 Jun;59(2):131-5
pubmed: 17571048
Arch Med Res. 2016 Jul;47(5):382-387
pubmed: 27751372
J Diabetes Complications. 2018 Mar;32(3):266-270
pubmed: 29395839
Biochem Med (Zagreb). 2013;23(2):143-9
pubmed: 23894860
Hum Reprod. 2007 Jul;22(7):1871-7
pubmed: 17478459
Reprod Biol Endocrinol. 2012 Dec 15;10:109
pubmed: 23241221
Eur Urol. 2021 Nov;80(5):603-620
pubmed: 34511305
Clin Lab. 2020 Nov 1;66(11):
pubmed: 33180424
Urology. 2021 Aug;154:148-157
pubmed: 33819517
J Clin Endocrinol Metab. 2018 May 1;103(5):1715-1744
pubmed: 29562364
Diabetes Res Clin Pract. 2011 Sep;93(3):e98-e100
pubmed: 21665314
Eur Urol Focus. 2020 Jan 15;6(1):178-183
pubmed: 30082228
Obes Surg. 2019 Jul;29(7):2045-2050
pubmed: 30806913
J Androl. 2002 Jan-Feb;23(1):25-43
pubmed: 11780920
PLoS One. 2013 Dec 31;8(12):e83951
pubmed: 24391852
Front Cell Dev Biol. 2021 Jul 22;9:689624
pubmed: 34368137
Curr Diabetes Rev. 2021;17(3):259-267
pubmed: 32814535
Andrology. 2016 Sep;4(5):944-51
pubmed: 27368157
Int J Impot Res. 2021 Dec 1;:
pubmed: 34853436
Andrology. 2021 Jan;9(1):238-244
pubmed: 32936988
Arch Androl. 1992 May-Jun;28(3):201-11
pubmed: 1530369
J Clin Endocrinol Metab. 2000 Jul;85(7):2402-10
pubmed: 10902785
Front Cell Dev Biol. 2021 Oct 21;9:727812
pubmed: 34746124
Minerva Urol Nefrol. 2018 Jun;70(3):286-299
pubmed: 29595040
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825

Auteurs

Federico Belladelli (F)

Division of Experimental Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, 20132 Milan, Italy.
Department of Urology, University Vita-Salute San Raffaele, 20132 Milan, Italy.

Luca Boeri (L)

Division of Experimental Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, 20132 Milan, Italy.
Department of Urology, Foundation IRCCS Ca' Granda-Ospedale Maggiore Policlinico, University of Milan, 20122 Milan, Italy.

Edoardo Pozzi (E)

Division of Experimental Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, 20132 Milan, Italy.
Department of Urology, University Vita-Salute San Raffaele, 20132 Milan, Italy.

Giuseppe Fallara (G)

Division of Experimental Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, 20132 Milan, Italy.
Department of Urology, University Vita-Salute San Raffaele, 20132 Milan, Italy.

Christian Corsini (C)

Division of Experimental Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, 20132 Milan, Italy.
Department of Urology, University Vita-Salute San Raffaele, 20132 Milan, Italy.

Luigi Candela (L)

Division of Experimental Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, 20132 Milan, Italy.
Department of Urology, University Vita-Salute San Raffaele, 20132 Milan, Italy.

Walter Cazzaniga (W)

Division of Experimental Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, 20132 Milan, Italy.
Department of Urology, University Vita-Salute San Raffaele, 20132 Milan, Italy.

Daniele Cignoli (D)

Division of Experimental Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, 20132 Milan, Italy.
Department of Urology, University Vita-Salute San Raffaele, 20132 Milan, Italy.

Luca Pagliardini (L)

Division of Genetics and Cell Biology, Reproductive Sciences Laboratory, IRCCS Ospedale San Raffaele, 20132 Milan, Italy.

Alessia D'Arma (A)

Division of Experimental Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, 20132 Milan, Italy.

Paolo Capogrosso (P)

Department of Urology and Andrology, Ospedale di Circolo and Macchi Foundation, 21100 Varese, Italy.

Eugenio Ventimiglia (E)

Division of Experimental Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, 20132 Milan, Italy.
Department of Urology, University Vita-Salute San Raffaele, 20132 Milan, Italy.

Francesco Montorsi (F)

Division of Experimental Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, 20132 Milan, Italy.
Department of Urology, University Vita-Salute San Raffaele, 20132 Milan, Italy.

Andrea Salonia (A)

Division of Experimental Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, 20132 Milan, Italy.
Department of Urology, University Vita-Salute San Raffaele, 20132 Milan, Italy.

Classifications MeSH